tiprankstipranks
Brainstorm Cell Therapeutics (DE:GHD)
FRANKFURT:GHD
Germany Market
GHD
Brainstorm Cell Therapeutics
RESEARCH TOOLSreports

Brainstorm Cell Therapeutics (GHD) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

GHD Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Brainstorm
Cell Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GHD Stock 12 Month Forecast

There Are No Analyst Ratings for DE:GHD In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

GHD Financial Forecast

GHD Earnings Forecast

The previous quarter’s earnings for GHD were -€0.17.
The previous quarter’s earnings for GHD were -€0.17.
No data currently available

GHD Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on DE:GHD
Jason McCarthy
Maxim Group
Maxim Group
―
Hold
―
Reiterated
08/15/25
Brainstorm Cell Therapeutics (BCLI) Receives a Hold from Maxim Group
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on DE:GHD
Jason McCarthy
Maxim Group
Maxim Group
―
Hold
―
Reiterated
08/15/25
Brainstorm Cell Therapeutics (BCLI) Receives a Hold from Maxim Group
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

GHD Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, GHD has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GHD average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

GHD Stock Forecast FAQ

What is DE:GHD’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:GHD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:GHD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
      Currently, no data Available
      What is Brainstorm Cell Therapeutics’s share price target?
      Currently, no data Available
      What do analysts say about Brainstorm Cell Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Brainstorm Cell Therapeutics?
      To buy shares of DE:GHD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.